IL-17a and IL-22 induce expression of antimicrobials in gastrointestinal epithelial cells and may contribute to epithelial cell defense against Helicobacter pylori

PLoS ONE

Volumn 11, Issue 2, 2016, Pages

  Dixon, Beverly R E A ^b   Radin, Jana N ^b,c   Piazuelo, M Blanca ^b   Contreras, Diana C ^b   Algood, Holly M Scott ^a,b  

^a Veteran's Affairs Tennessee Valley Healthcare System   (United States)

^b VANDERBILT UNIVERSITY   (United States)

^c UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMICROBIAL PROTEIN; BETA DEFENSIN; CALGRANULIN; CALGRANULIN A; CALGRANULIN B; CELL PROTEIN; CHEMOKINE; INTERLEUKIN 17; INTERLEUKIN 22; INTERLEUKIN 8; LIPOCALIN; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; RECOMBINANT CYTOKINE; UNCLASSIFIED DRUG; ANTIINFECTIVE AGENT; IL17A PROTEIN, HUMAN; IL17A PROTEIN, MOUSE; IL8 PROTEIN, HUMAN; INTERLEUKIN DERIVATIVE; INTERLEUKIN-22;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL VIRULENCE; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; EPITHELIUM CELL; GASTROINTESTINAL EPITHELIUM CELL; GENETIC TRANSCRIPTION; HELICOBACTER INFECTION; HELICOBACTER PYLORI; IMMUNE RESPONSE; IN VITRO STUDY; INFLAMMATION; MALE; MOUSE; MOUSE MODEL; NONHUMAN; TH17 CELL; ANIMAL; BIOSYNTHESIS; C57BL MOUSE; CD4+ T LYMPHOCYTE; CHEMISTRY; EPITHELIUM; GASTRITIS; GASTROINTESTINAL TRACT; GENETICS; HUMAN; IMMUNOLOGY; METABOLISM; MICROBIOLOGY; PATHOLOGY; REAL TIME POLYMERASE CHAIN REACTION; STOMACH; TRANSGENIC MOUSE;

ANIMALS; ANTI-INFECTIVE AGENTS; CD4-POSITIVE T-LYMPHOCYTES; EPITHELIAL CELLS; EPITHELIUM; GASTRITIS; GASTROINTESTINAL TRACT; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; INFLAMMATION; INTERLEUKIN-17; INTERLEUKIN-8; INTERLEUKINS; LEUKOCYTE L1 ANTIGEN COMPLEX; LIPOCALINS; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; REAL-TIME POLYMERASE CHAIN REACTION; STOMACH;

EID: 84959331323     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0148514     Document Type: Article

References (74)

1. Noto JM, Peek RM Jr. Helicobacter pylori: an overview. Methods Mol Biol. 2012; 921:7-10. Epub 2012/09/28. doi: 10.1007/978-1-62703-005-2-2 PMID: 23015485.
2. Bauer B, Meyer TF. The Human Gastric Pathogen Helicobacter pylori and Its Association with Gastric Cancer and Ulcer Disease. Ulcer. 2011;Article ID 340157:23. PubMed Central PMCID: PMCNone.
3. De Falco M, Lucariello A, Iaquinto S, Esposito V, Guerra G, De Luca A. Molecular Mechanisms of Helicobacter pylori Pathogenesis. Journal of cellular physiology. 2015; 230(8):1702-7. doi: 10.1002/jcp. 24933 PMID: 25639461.
4. Ferreira RM, Machado JC, Figueiredo C. Clinical relevance of Helicobacter pylori vacA and cagA genotypes in gastric carcinoma. Best practice & research Clinical gastroenterology. 2014; 28(6):1003-15. doi: 10.1016/j.bpg.2014.09.004 PMID: 25439067.
5. Yamaoka Y, Graham DY. Helicobacter pylori virulence and cancer pathogenesis. Future oncology. 2014; 10(8):1487-500. doi: 10.2217/fon.14.29 PMID: 25052757; PubMed Central PMCID: PMC4197059.
6. Cover TL, Peek RM Jr. Diet, microbial virulence, and Helicobacter pylori-induced gastric cancer. Gut microbes. 2013; 4(6):482-93. doi: 10.4161/gmic.26262 PMID: 23989802; PubMed Central PMCID: PMC3928160.
7. Gaddy JA, Radin JN, Loh JT, Zhang F, Washington MK, Peek RM Jr. et al. High dietary salt intake exacerbates Helicobacter pylori-induced gastric carcinogenesis. Infect Immun. 2013; 81(6):2258-67. doi: 10.1128/IAI.01271-12 PMID: 23569116; PubMed Central PMCID: PMC3676043.
8. Noto JM, Lee JY, Gaddy JA, Cover TL, Amieva MR, Peek RM Jr. Regulation of Helicobacter pylori Virulence Within the Context of Iron Deficiency. J Infect Dis. 2015; 211(11):1790-4. doi: 10.1093/infdis/jiu805 PMID: 25505301; PubMed Central PMCID: PMC4447831.
9. Noto JM, Gaddy JA, Lee JY, Piazuelo MB, Friedman DB, Colvin DC, et al. Iron deficiency accelerates Helicobacter pylori-induced carcinogenesis in rodents and humans. J Clin Invest. 2013; 123(1):479-92.
10. Karttunen R, Karttunen T, Ekre HP, MacDonald TT. Interferon gamma and interleukin 4 secreting cells in the gastric antrum in Helicobacter pylori positive and negative gastritis. Gut. 1995; 36(3):341-5. PMID: 7698689
11. Haeberle HA, Kubin M, Bamford KB, Garofalo R, Graham DY, El-Zaatari F, et al. Differential stimulation of interleukin-12 (IL-12) and IL-10 by live and killed Helicobacter pylori in vitro and association of IL-12 production with gamma interferon-producing T cells in the human gastric mucosa. Infection & Immunity. 1997; 65(10):4229-35.
12. Bamford KB, Fan X, Crowe SE, Leary JF, Gourley WK, Luthra GK, et al. Lymphocytes in the human gastric mucosa during Helicobacter pylori have a T helper cell 1 phenotype. Gastroenterology. 1998; 114(3):482-92. PMID: 9496938
13. Lindholm C, Quiding-Jarbrink M, Lonroth H, Hamlet A, Svennerholm AM. Local cytokine response in Helicobacter pylori-infected subjects. Infection & Immunity. 1998; 66(12):5964-71.
14. Sommer F, Faller G, Konturek P, Kirchner T, Hahn EG, Zeus J, et al. Antrum- and corpus mucosa-infiltrating CD4(+) lymphocytes in Helicobacter pylori gastritis display a Th1 phenotype. Infection & Immunity. 1998; 66(11):5543-6.
15. Luzza F, Parrello T, Sebkova L, Pensabene L, Imeneo M, Mancuso M, et al. Expression of proinflammatory and Th1 but not Th2 cytokines is enhanced in gastric mucosa of Helicobacter pylori infected children. Digestive & Liver Disease. 2001; 33(1):14-20.
16. Itoh T, Yoshida M, Chiba T, Kita T, Wakatsuki Y. A coordinated cytotoxic effect of IFN-gamma and cross-reactive antibodies in the pathogenesis of Helicobacter pylori gastritis. Helicobacter. 2003; 8 (4):268-78. PMID: 12950599
17. Mizuno T, Ando T, Nobata K, Tsuzuki T, Maeda O, Watanabe O, et al. Interleukin-17 levels in Helicobacter pylori-infected gastric mucosa and pathologic sequelae of colonization. World J Gastroenterol. 2005; 11(40):6305-11.
18. Caruso R, Fina D, Paoluzi OA, Del Vecchio Blanco G, Stolfi C, Rizzo A, et al. IL-23-mediated regulation of IL-17 production in Helicobacter pylori-infected gastric mucosa. Eur J Immunol. 2008; 38(2):470-8. PMID: 18200634. doi: 10.1002/eji.200737635
19. Algood HM, Gallo-Romero J, Wilson KT, Peek RM Jr., Cover TL. Host response to Helicobacter pylori infection before initiation of the adaptive immune response. FEMS Immunol Med Microbiol. 2007; 51 (3):577-86. PMID: 17919297.
20. Sugimoto M, Ohno T, Graham DY, Yamaoka Y. Gastric mucosal interleukin-17 and -18 mRNA expression in Helicobacter pylori-induced Mongolian gerbils. Cancer science. 2009; 100(11):2152-9. Epub 2009/08/22. doi: 10.1111/j.1349-7006.2009.01291.x PMID: 19694753; PubMed Central PMCID: PMC3128813.
21. Horvath DJ Jr., Washington MK, Cope VA, Algood HM. IL-23 contributes to control of chronic Helicobacter pylori infection and the development of T helper responses in a mouse model. Frontiers in immunology. 2012; 3:56. Epub 2012/05/09. doi: 10.3389/fimmu.2012.00056 PMID: 22566937; PubMed Central PMCID: PMC3342083.
22. Carbo A, Olivares-Villagomez D, Hontecillas R, Bassaganya-Riera J, Chaturvedi R, Piazuelo MB, et al. Systems Modeling of the Role of Interleukin-21 in the Maintenance of Effector CD4+ T Cell Responses during Chronic Helicobacter pylori Infection. mBio. 2014; 5(4).
23. Shiomi S, Toriie A, Imamura S, Konishi H, Mitsufuji S, Iwakura Y, et al. IL-17 is Involved in Helicobacter pylori-Induced Gastric Inflammatory Responses in a Mouse Model. Helicobacter. 2008; 13(6):518-24. PMID: 19166417. doi: 10.1111/j.1523-5378.2008.00629.x
24. Algood HM, Allen SS, Washington MK, Peek RM Jr., Miller GG, Cover TL. Regulation of gastric B cell recruitment is dependent on IL-17 receptor A signaling in a model of chronic bacterial infection. J Immunol. 2009; 183(9):5837-46. Epub 2009/10/09. doi: 10.4049/jimmunol.0901206 PMID: 19812196; PubMed Central PMCID: PMC2834183.
25. Otani K, Watanabe T, Tanigawa T, Okazaki H, Yamagami H, Watanabe K, et al. Anti-inflammatory effects of IL-17A on Helicobacter pylori-induced gastritis. Biochemical and biophysical research communications. 2009; 382(2):252-8.
26. Carbo A, Hontecillas R, Hoops S, Kronsteiner B, Marathe M, Eubank S, et al. Modeling of molecular mechanisms controlling CD4+ T cell differentiation and phenotype plasticity. PNAS. 2012;Pending publication.
27. Zhuang Y, Cheng P, Liu XF, Peng LS, Li BS, Wang TT, et al. A pro-inflammatory role for Th22 cells in Helicobacter pylori-associated gastritis. Gut. 2014. doi: 10.1136/gutjnl-2014-307020 PMID: 25134787.
28. Liu T, Peng L, Yu P, Zhao Y, Shi Y, Mao X, et al. Increased circulating Th22 and Th17 cells are associated with tumor progression and patient survival in human gastric cancer. Journal of clinical immunology. 2012; 32(6):1332-9. doi: 10.1007/s10875-012-9718-8 PMID: 22760549.
29. Zhuang Y, Peng LS, Zhao YL, Shi Y, Mao XH, Guo G, et al. Increased intratumoral IL-22-producing CD4(+) T cells and Th22 cells correlate with gastric cancer progression and predict poor patient survival. Cancer immunology, immunotherapy: CII. 2012; 61(11):1965-75. doi: 10.1007/s00262-012-1241-5 PMID: 22527243.
30. Zheng Y, Valdez PA, Danilenko DM, Hu Y, Sa SM, Gong Q, et al. Interleukin-22 mediates early host defense against attaching and effacing bacterial pathogens. Nat Med. 2008; 14(3):282-9. Epub 2008/02/12. nm1720 [pii] doi: 10.1038/nm1720 PMID: 18264109.
31. Aujla SJ, Chan YR, Zheng M, Fei M, Askew DJ, Pociask DA, et al. IL-22 mediates mucosal host defense against Gram-negative bacterial pneumonia. Nature medicine. 2008; 14(3):275-81. doi: 10.1038/nm1710 PMID: 18264110; PubMed Central PMCID: PMC2901867.
32. Eidenschenk C, Rutz S, Liesenfeld O, Ouyang W. Role of IL-22 in microbial host defense. Curr Top Microbiol Immunol. 2014; 380:213-36. doi: 10.1007/978-3-662-43492-5-10 PMID: 25004820.
33. Liu JZ, Pezeshki M, Raffatellu M. Th17 cytokines and host-pathogen interactions at the mucosa: dichotomies of help and harm. Cytokine. 2009; 48(1-2):156-60.
34. Wozniak KL, Hole CR, Yano J, Fidel PL Jr., Wormley FL Jr. Characterization of IL-22 and antimicrobial peptide production in mice protected against pulmonary Cryptococcus neoformans infection. Microbiology. 2014; 160(Pt 7):1440-52.
35. Conti P, Kempuraj D, Frydas S, Kandere K, Boucher W, Letourneau R, et al. IL-10 subfamily members: IL-19, IL-20, IL-22, IL-24 and IL-26. Immunol Lett. 2003; 88(3):171-4. PMID: 12941475.
36. Basu R, O'Quinn DB, Silberger DJ, Schoeb TR, Fouser L, Ouyang W, et al. Th22 cells are an important source of IL-22 for host protection against enteropathogenic bacteria. Immunity. 2012; 37(6):1061-75.
37. Basu R, Hatton RD, Weaver CT. The Th17 family: flexibility follows function. Immunological reviews. 2013; 252(1):89-103. doi: 10.1111/imr.12035 PMID: 23405897; PubMed Central PMCID: PMC3607325.
38. Lejeune D, Dumoutier L, Constantinescu S, Kruijer W, Schuringa JJ, Renauld JC. Interleukin-22 (IL-22) activates the JAK/STAT, ERK, JNK, and p38 MAP kinase pathways in a rat hepatoma cell line. Pathways that are shared with and distinct from IL-10. J Biol Chem. 2002; 277(37):33676-82. doi: 10.1074/jbc.M204204200 PMID: 12087100.
39. Xiang X, Gui H, King NJ, Cole L, Wang H, Xie Q, et al. IL-22 and non-ELR-CXC chemokine expression in chronic hepatitis B virus-infected liver. Immunol Cell Biol. 2012; 90(6):611-9. doi: 10.1038/icb.2011. 79 PMID: 21946664.
40. Boniface K, Bernard FX, Garcia M, Gurney AL, Lecron JC, Morel F. IL-22 inhibits epidermal differentiation and induces proinflammatory gene expression and migration of human keratinocytes. J Immunol. 2005; 174(6):3695-702. PMID: 15749908.
41. Sugimoto K, Ogawa A, Mizoguchi E, Shimomura Y, Andoh A, Bhan AK, et al. IL-22 ameliorates intestinal inflammation in a mouse model of ulcerative colitis. J Clin Invest. 2008; 118(2):534-44.
42. Liang SC, Nickerson-Nutter C, Pittman DD, Carrier Y, Goodwin DG, Shields KM, et al. IL-22 induces an acute-phase response. J Immunol. 2010; 185(9):5531-8. doi: 10.4049/jimmunol.0904091 PMID: 20870942.
43. Ji Y, Yang X, Li J, Lu Z, Li X, Yu J, et al. IL-22 promotes the migration and invasion of gastric cancer cells via IL-22R1/AKT/MMP-9 signaling. International journal of clinical and experimental pathology. 2014; 7(7):3694-703. PMID: 25120745; PubMed Central PMCID: PMC4128980.
44. Wolk K, Witte E, Wallace E, Docke WD, Kunz S, Asadullah K, et al. IL-22 regulates the expression of genes responsible for antimicrobial defense, cellular differentiation, and mobility in keratinocytes: a potential role in psoriasis. Eur J Immunol. 2006; 36(5):1309-23. doi: 10.1002/eji.200535503 PMID: 16619290.
45. Liao F, Hsu YC, Kuo SH, Yang YC, Chen JP, Hsu PN, et al. Genetic polymorphisms and tissue expression of interleukin-22 associated with risk and therapeutic response of gastric mucosa-associated lymphoid tissue lymphoma. Blood cancer journal. 2014; 4:eXX. doi: 10.1038/bcj.2014.70 PMID: 25303370; PubMed Central PMCID: PMC4220648.
46. Liang SC, Tan XY, Luxenberg DP, Karim R, Dunussi-Joannopoulos K, Collins M, et al. Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides. J Exp Med. 2006; 203(10):2271-9.
47. Wroblewski LE, Piazuelo MB, Chaturvedi R, Schumacher M, Aihara E, Feng R, et al. Helicobacter pylori targets cancer-associated apical-junctional constituents in gastroids and gastric epithelial cells. Gut. 2015; 64(5):720-30. doi: 10.1136/gutjnl-2014-307650 PMID: 25123931; PubMed Central PMCID: PMC4329117.
48. Andoh A, Zhang Z, Inatomi O, Fujino S, Deguchi Y, Araki Y, et al. Interleukin-22, a member of the IL-10 subfamily, induces inflammatory responses in colonic subepithelial myofibroblasts. Gastroenterology. 2005; 129(3):969-84. doi: 10.1053/j.gastro.2005.06.071 PMID: 16143135.
49. Nakagome K, Imamura M, Kawahata K, Harada H, Okunishi K, Matsumoto T, et al. High expression of IL-22 suppresses antigen-induced immune responses and eosinophilic airway inflammation via an IL-10-associated mechanism. J Immunol. 2011; 187(10):5077-89. doi: 10.4049/jimmunol.1001560 PMID: 21998459.
50. Rutz S, Wang X, Ouyang W. The IL-20 subfamily of cytokines-from host defence to tissue homeostasis. Nature reviews Immunology. 2014; 14(12):783-95. doi: 10.1038/nri3766 PMID: 25421700.
51. Jia L, Wu C. The biology and functions of Th22 cells. Advances in experimental medicine and biology. 2014; 841:209-30. doi: 10.1007/978-94-017-9487-9-8 PMID: 25261209.
52. Busman-Sahay KO, Walrath T, Huber S, O'Connor W Jr. Cytokine crowdsourcing: multicellular production of TH17-associated cytokines. J Leukoc Biol. 2015; 97(3):499-510.
53. Sabat R, Ouyang W, Wolk K. Therapeutic opportunities of the IL-22-IL-22R1 system. Nature reviews Drug discovery. 2014; 13(1):21-38.
54. Carrion M, Juarranz Y, Martinez C, Gonzalez-Alvaro I, Pablos JL, Gutierrez-Canas I, et al. IL-22/IL-22R1 axis and S100A8/A9 alarmins in human osteoarthritic and rheumatoid arthritis synovial fibroblasts. Rheumatology. 2013; 52(12):2177-86. doi: 10.1093/rheumatology/ket315 PMID: 24056519.
55. Gaddy JA, Radin JN, Loh JT, Piazuelo MB, Kehl-Fie TE, Delgado AG, et al. The host protein calprotectin modulates the Helicobacter pylori cag type IV secretion system via zinc sequestration. PLoS pathogens. 2014; 10(10):e1004450.
56. Ghavami S, Kerkhoff C, Chazin WJ, Kadkhoda K, Xiao W, Zuse A, et al. S100A8/9 induces cell death via a novel, RAGE-independent pathway that involves selective release of Smac/DIABLO and Omi/HtrA2. Biochimica et biophysica acta. 2008; 1783(2):297-311.
57. Tsai SY, Segovia JA, Chang TH, Morris IR, Berton MT, Tessier PA, et al. DAMP molecule S100A9 acts as a molecular pattern to enhance inflammation during influenza A virus infection: role of DDX21-TRIFTLR4-MyD88 pathway. PLoS pathogens. 2014; 10(1):e1003848. doi: 10.1371/journal.ppat.1003848 PMID: 24391503; PubMed Central PMCID: PMC3879357.
58. Rahman MT, Myles A, Gaur P, Misra R, Aggarwal A. TLR4 endogenous ligand MRP8/14 level in enthesitis-related arthritis and its association with disease activity and TLR4 expression. Rheumatology. 2014; 53(2):270-4.
59. Liu JZ, Jellbauer S, Poe AJ, Ton V, Pesciaroli M, Kehl-Fie TE, et al. Zinc sequestration by the neutrophil protein calprotectin enhances Salmonella growth in the inflamed gut. Cell host & microbe. 2012; 11 (3):227-39. Epub 2012/03/20. doi: 10.1016/j.chom.2012.01.017 PMID: 22423963; PubMed Central PMCID: PMC3308348.
60. Corbin BD, Seeley EH, Raab A, Feldmann J, Miller MR, Torres VJ, et al. Metal chelation and inhibition of bacterial growth in tissue abscesses. Science. 2008; 319(5865):962-5. doi: 10.1126/science. 1152449 PMID: 18276893.
61. Kehl-Fie TE, Chitayat S, Hood MI, Damo S, Restrepo N, Garcia C, et al. Nutrient metal sequestration by calprotectin inhibits bacterial superoxide defense, enhancing neutrophil killing of Staphylococcus aureus. Cell host & microbe. 2011; 10(2):158-64.
62. Ota N, Wong K, Valdez PA, Zheng Y, Crellin NK, Diehl L, et al. IL-22 bridges the lymphotoxin pathway with the maintenance of colonic lymphoid structures during infection with Citrobacter rodentium. Nat Immunol. 2011; 12(10):941-8.
63. Zindl CL, Lai JF, Lee YK, Maynard CL, Harbour SN, Ouyang W, et al. IL-22-producing neutrophils contribute to antimicrobial defense and restitution of colonic epithelial integrity during colitis. Proc Natl Acad Sci U S A. 2013; 110(31):12768-73. doi: 10.1073/pnas.1300318110 PMID: 23781104; PubMed Central PMCID: PMC3732935.
64. Manta C, Heupel E, Radulovic K, Rossini V, Garbi N, Riedel CU, et al. CX(3)CR1(+) macrophages support IL-22 production by innate lymphoid cells during infection with Citrobacter rodentium. Mucosal immunology. 2013; 6(1):177-88.
65. Graham AC, Carr KD, Sieve AN, Indramohan M, Break TJ, Berg RE. IL-22 production is regulated by IL-23 during Listeria monocytogenes infection but is not required for bacterial clearance or tissue protection. PloS one. 2011; 6(2):e17171.
66. Behrends J, Renauld JC, Ehlers S, Holscher C. IL-22 is mainly produced by IFNgamma-secreting cells but is dispensable for host protection against Mycobacterium tuberculosis infection. PloS one. 2013; 8 (2):e57379.
67. Behnsen J, Jellbauer S, Wong CP, Edwards RA, George MD, Ouyang W, et al. The cytokine IL-22 promotes pathogen colonization by suppressing related commensal bacteria. Immunity. 2014; 40(2):262-73. doi: 10.1016/j.immuni.2014.01.003 PMID: 24508234; PubMed Central PMCID: PMC3964146.
68. Allen AJ, Park KT, Barrington GM, Lahmers KK, Abdellrazeq GS, Rihan HM, et al. Experimental infection of a bovine model with human isolates of Mycobacterium avium subsp. paratuberculosis. Veterinary immunology and immunopathology. 2011; 141(3-4):258-66.
69. Wilson MS, Feng CG, Barber DL, Yarovinsky F, Cheever AW, Sher A, et al. Redundant and pathogenic roles for IL-22 in mycobacterial, protozoan, and helminth infections. J Immunol. 2010; 184(8):4378-90. doi: 10.4049/jimmunol.0903416 PMID: 20220096; PubMed Central PMCID: PMC3170015.
70. Harper EG, Guo C, Rizzo H, Lillis JV, Kurtz SE, Skorcheva I, et al. Th17 cytokines stimulate CCL20 expression in keratinocytes in vitro and in vivo: implications for psoriasis pathogenesis. The Journal of investigative dermatology. 2009; 129(9):2175-83. doi: 10.1038/jid.2009.65 PMID: 19295614; PubMed Central PMCID: PMC2892172.
71. Kanda N, Shibata S, Tada Y, Nashiro K, Tamaki K, Watanabe S. Prolactin enhances basal and IL-17-induced CCL20 production by human keratinocytes. Eur J Immunol. 2009; 39(4):996-1006. doi: 10.1002/eji.200838852 PMID: 19350575.
72. Chen JP, Wu MS, Kuo SH, Liao F. IL-22 negatively regulates Helicobacter pylori-induced CCL20 expression in gastric epithelial cells. PloS one. 2014; 9(5):e97350.
73. Hepworth MR, Monticelli LA, Fung TC, Ziegler CG, Grunberg S, Sinha R, et al. Innate lymphoid cells regulate CD4+ T-cell responses to intestinal commensal bacteria. Nature. 2013; 498(7452):113-7. doi: 10.1038/nature12240 PMID: 23698371; PubMed Central PMCID: PMC3699860.
74. Li LJ, Gong C, Zhao MH, Feng BS. Role of interleukin-22 in inflammatory bowel disease. World J Gastroenterol. 2014; 20(48):18177-88. doi: 10.3748/wjg.v20.i48.18177 PMID: 25561785; PubMed Central PMCID: PMC4277955.